Immune cell delivery platforms for tumor therapy: From empirical approaches to AI-integrated frameworks
Authors:
- 2 June 2026
- journal article
- review article
- Published by Elsevier in Journal of Controlled Release
- Vol. 396, 115065
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (22501245)
- Zhejiang University
- Ministry of Science and Technology of the People's Republic of China (2023ZD0121002)
This publication has 196 references indexed in Scilit:
- Ultrasonic Cavitation‐Manipulated Macrophages Hitchhiking Augments Delivery of Nanocarriers for Active and Efficient Cancer TherapyAdvanced Healthcare Materials, 2025
- Differentiation Responsive Architected Macrophage (DREAM) Selectively Modulate Tumor Microenvironment for Cancer ImmunotherapyAdvanced Functional Materials, 2025
- Understanding Structure–Function Relationships of Nanoadjuvants for Enhanced Cancer Vaccine EfficacyAdvanced Functional Materials, 2022
- Neutrophil Cyto‐Pharmaceuticals Suppressing Tumor Metastasis via Inhibiting Hypoxia‐Inducible Factor‐1α in Circulating Breast Cancer CellsAdvanced Healthcare Materials, 2021
- Supramolecular Macrophage‐Liposome Marriage for Cell‐Hitchhiking Delivery and Immunotherapy of Acute Pneumonia and MelanomaAdvanced Functional Materials, 2021
- Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast CancerJAMA Oncology, 2019
- Dendritic Cell Membrane Vesicles for Activation and Maintenance of Antigen‐Specific T CellsAdvanced Healthcare Materials, 2018
- Nanoparticle‐Laden Macrophages for Tumor‐Tropic Drug DeliveryAdvanced Materials, 2018
- Neutrophil‐Based Drug Delivery SystemsAdvanced Materials, 2018
- Cell‐Based Drug Delivery and Use of Nano‐and Microcarriers for Cell FunctionalizationAdvanced Healthcare Materials, 2017